US Stock MarketDetailed Quotes

MXRX Med-X

Watchlist

4.000
0.0000.00%

Close Nov 1 16:00 ET

21.49MMarket Cap-3030P/E (TTM)

Med-X Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

30.82%-1.27M

-9.41%-4.88M

-982.32K

-1.84M

-35.07%-4.46M

-3.3M

Net income from continuing operations

22.16%-1.13M

-47.66%-7.34M

---2.96M

---1.45M

-40.36%-4.97M

---3.54M

Operating gains losses

----

---319.61K

----

Depreciation and amortization

79.22%10.18K

-27.19%29.04K

--10.42K

--5.68K

-64.67%39.89K

--112.9K

Other non cash items

-83.33%1.8K

78.85%1.91M

--1.89M

--10.78K

191.66%1.07M

--366.59K

Change In working capital

61.81%-153.81K

281.61%511.41K

--82.17K

---402.72K

-17.18%-281.6K

---240.3K

-Change in receivables

83.39%-17.84K

-130.01%-36.68K

---9.86K

---107.43K

225.46%122.23K

---97.43K

-Change in inventory

326.14%95.2K

179.53%162.12K

---15.3K

---42.1K

-2,254.85%-203.84K

---8.66K

-Change in prepaid assets

88.62%-21.93K

141.42%69.54K

---33.37K

---192.8K

-411.24%-167.89K

--53.94K

-Change in payables and accrued expense

-246.45%-209.24K

1,085.69%316.44K

--140.7K

---60.39K

82.94%-32.1K

---188.16K

Cash from discontinued investing activities

Operating cash flow

30.82%-1.27M

-9.41%-4.88M

---982.32K

---1.84M

-35.07%-4.46M

---3.3M

Investing cash flow

Cash flow from continuing investing activities

-241.88%-48.71K

1,004.45%34.33K

-3.8K

Net PPE purchase and sale

----

-241.88%-48.71K

----

1,004.45%34.33K

---3.8K

Cash from discontinued investing activities

Investing cash flow

--0

-241.88%-48.71K

---48.71K

--0

1,004.45%34.33K

---3.8K

Financing cash flow

Cash flow from continuing financing activities

12.06%1.27M

-25.20%3.77M

841.44K

1.13M

31.47%5.04M

3.83M

Net issuance payments of debt

-104.98%-3.95K

770.39%523.99K

--12.57K

--79.41K

-125.48%-78.16K

--306.71K

Net common stock issuance

20.87%1.27M

-36.58%3.25M

--828.87K

--1.05M

45.12%5.12M

--3.53M

Cash from discontinued financing activities

Financing cash flow

12.06%1.27M

-25.20%3.77M

--841.44K

--1.13M

31.47%5.04M

--3.83M

Net cash flow

Beginning cash position

-84.68%209.47K

81.62%1.37M

--662.88K

--1.37M

234.61%752.82K

--224.98K

Current changes in cash

99.82%-1.27K

-288.43%-1.16M

---189.59K

---704.4K

16.41%614.46K

--527.84K

End cash Position

-68.59%208.21K

-84.68%209.47K

--473.38K

--662.88K

81.62%1.37M

--752.82K

Free cash flow

30.82%-1.27M

-10.46%-4.93M

---1.03M

---1.84M

-34.96%-4.46M

---3.31M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	30.82%-1.27M	-9.41%-4.88M	-982.32K	-1.84M	-35.07%-4.46M	-3.3M
Net income from continuing operations	22.16%-1.13M	-47.66%-7.34M	---2.96M	---1.45M	-40.36%-4.97M	---3.54M
Operating gains losses	----	----	----	----	---319.61K	----
Depreciation and amortization	79.22%10.18K	-27.19%29.04K	--10.42K	--5.68K	-64.67%39.89K	--112.9K
Other non cash items	-83.33%1.8K	78.85%1.91M	--1.89M	--10.78K	191.66%1.07M	--366.59K
Change In working capital	61.81%-153.81K	281.61%511.41K	--82.17K	---402.72K	-17.18%-281.6K	---240.3K
-Change in receivables	83.39%-17.84K	-130.01%-36.68K	---9.86K	---107.43K	225.46%122.23K	---97.43K
-Change in inventory	326.14%95.2K	179.53%162.12K	---15.3K	---42.1K	-2,254.85%-203.84K	---8.66K
-Change in prepaid assets	88.62%-21.93K	141.42%69.54K	---33.37K	---192.8K	-411.24%-167.89K	--53.94K
-Change in payables and accrued expense	-246.45%-209.24K	1,085.69%316.44K	--140.7K	---60.39K	82.94%-32.1K	---188.16K
Cash from discontinued investing activities
Operating cash flow	30.82%-1.27M	-9.41%-4.88M	---982.32K	---1.84M	-35.07%-4.46M	---3.3M
Investing cash flow
Cash flow from continuing investing activities		-241.88%-48.71K			1,004.45%34.33K	-3.8K
Net PPE purchase and sale	----	-241.88%-48.71K	----	----	1,004.45%34.33K	---3.8K
Cash from discontinued investing activities
Investing cash flow	--0	-241.88%-48.71K	---48.71K	--0	1,004.45%34.33K	---3.8K
Financing cash flow
Cash flow from continuing financing activities	12.06%1.27M	-25.20%3.77M	841.44K	1.13M	31.47%5.04M	3.83M
Net issuance payments of debt	-104.98%-3.95K	770.39%523.99K	--12.57K	--79.41K	-125.48%-78.16K	--306.71K
Net common stock issuance	20.87%1.27M	-36.58%3.25M	--828.87K	--1.05M	45.12%5.12M	--3.53M
Cash from discontinued financing activities
Financing cash flow	12.06%1.27M	-25.20%3.77M	--841.44K	--1.13M	31.47%5.04M	--3.83M
Net cash flow
Beginning cash position	-84.68%209.47K	81.62%1.37M	--662.88K	--1.37M	234.61%752.82K	--224.98K
Current changes in cash	99.82%-1.27K	-288.43%-1.16M	---189.59K	---704.4K	16.41%614.46K	--527.84K
End cash Position	-68.59%208.21K	-84.68%209.47K	--473.38K	--662.88K	81.62%1.37M	--752.82K
Free cash flow	30.82%-1.27M	-10.46%-4.93M	---1.03M	---1.84M	-34.96%-4.46M	---3.31M
Currency Unit	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall